Mission Produce reaffirms second-half fiscal 2026 Adjusted EBITDA outlook of $84 million-$88 million
Bitget2026/10/08 12:20Mission Produce reaffirmed fiscal 2026 second-half Adjusted EBITDA of $84 million-$88 million, including fourth-quarter Adjusted EBITDA of $52 million-$55 million. Second-half Mission Peru exportable volume outlook held at 120 million-130 million pounds, including 67 million-77 million pounds in the fourth quarter. Five-year targets call for mid-single-digit organic sales growth, roughly 300 basis points of margin expansion, cash conversion above 90% of Adjusted Net Income. Framework assumes high-single-digit organic Adjusted EBITDA growth over five years, supported by Calavo synergies and higher asset utilization. Annualized Calavo synergy target raised to more than $30 million from at least $25 million, with a small fiscal Q4 2026 contribution expected. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mission Produce Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001802974-26-000046), on October 08, 2026, and is solely responsible for the information contained therein.
- Mission Produce reaffirmed fiscal 2026 second-half Adjusted EBITDA of $84 million-$88 million, including fourth-quarter Adjusted EBITDA of $52 million-$55 million.
- Second-half Mission Peru exportable volume outlook held at 120 million-130 million pounds, including 67 million-77 million pounds in the fourth quarter.
- Five-year targets call for mid-single-digit organic sales growth, roughly 300 basis points of margin expansion, cash conversion above 90% of Adjusted Net Income.
- Framework assumes high-single-digit organic Adjusted EBITDA growth over five years, supported by Calavo synergies and higher asset utilization.
- Annualized Calavo synergy target raised to more than $30 million from at least $25 million, with a small fiscal Q4 2026 contribution expected.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CoreWeave (CRWV.US) plunges 15%: Citi (C.US) says rate pressures hit Neocloud, Microsoft (MSFT.US) cash flow advantage stands out
CoreWeave plunged 15% in a single day, triggering market volatility. Citi analyst Tyler Radke pointed out that high borrowing costs are severely impacting Neocloud companies that rely on debt financing. In contrast, Microsoft demonstrates notable resilience during the AI funding tightening cycle thanks to its strong free cash flow and debt-free advantage.

SoftBank Group’s credit risk rises to a four-year high, as AI bets and acquisition rumors heighten leverage concerns
Due to increased market concerns over AI-related financing and potential large-scale acquisitions, SoftBank Group's credit risk indicator—the credit default swap (CDS)—has risen to its highest level in nearly four years.

Microsoft (MSFT.US) faces a "higher bar" after its rebound! Morgan Stanley remains bullish: Azure growth and Copilot commercialization are key drivers, target price set at $600
Morgan Stanley stated that Microsoft's stock price has recently rebounded, so the tech giant will face a "higher hurdle" if it wants to maintain its upward momentum.

Report: OpenAI plans to accelerate fundraising before Anthropic goes public
OpenAI is racing against time—in order to secure funding ahead of rival Anthropic’s IPO, the company has significantly compressed its fundraising timeline, aiming to complete approximately $30 billion in private financing, which could push its valuation past $1.4 trillion upon completion. Major investors such as SoftBank and MGX are already engaged in discussions. Both AI giants are targeting trillion-dollar valuations, and their largely overlapping investor bases are being forced to make simultaneous bets on both ventures within just a few days.
